A Study on Building a Voice Cohort for the Development of a Non-face-to-face Machine Learning Diagnostic and Monitoring Platform Using Voice Analysis and Various Sensors in Patients With Dysphagia.
NCT ID: NCT05439447
Last Updated: 2025-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
246 participants
OBSERVATIONAL
2023-04-07
2024-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishment of Voice Analysis Cohort for Development of Monitoring Technology for Dysphagia
NCT05149976
Dysphagia Study Using Novel Microphone Device
NCT07251140
Treatment of Dysphagia by Using a Synchronized Electrical Stimulation Device
NCT02718963
Establish Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment
NCT02243722
Evaluation of Dysphagia by 6-chnnel Surface Electromyography
NCT03494361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Setting : Hospital rehabilitation department
* Inclusion criteria of the patient group : Patients scheduled for VFSS examination
* Intervention
* This study will be conducted after collecting basic information such as age, gender, and disease of patients who met the inclusion criteria among patients scheduled to undergo a video fluoroscopic swallowing test (VFSS test) for the diagnosis of dysphagia, and after obtaining guidance and consent through the study description will do.
* Before the subject's VFSS test, "Ah for 5 seconds", after clearing the throat, "Ah for 5 seconds", and briefly cut with a slightly high sound, "Ah. oh Ah.", shut lips lightly and read "Ummm\~\~\~\~", read a short sentence.
* While the subject makes the above sound, voice is recorded, video is taken, and integrated sensors such as a microphone (sound detection) sensor and surface electromyography sensor are attached to measure changes in each sensor.
* After the VFSS test, participants will repeat the above sound and record the same twice. (As before the test, imaging of the patient's swallowing is also performed.)
* Using voice analysis, various sensor values, and image information, a voice indicator that can predict the amount of suction and residue on the VFSS test is found.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients scheduled for VFSS examination due to dysphagia.
Patients scheduled for VFSS testing group
Patients scheduled for VFSS testing, patient with voice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients scheduled for VFSS testing group
Patients scheduled for VFSS testing, patient with voice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Patients who can record voices such as "Ah.", "Ummm\~\~\~", short sentences
* Patients who can attach sensor on their throat
* Those who voluntarily consent to the clinical trial
* Those who do not agree to participate in this study
* Patients who can not follow Step 1 instructions
* Patients who can not vocalize or follow to speak
* Patients who cannot apply the sensor due to skin allergy or hypersensitivity to sensor attachment
* Other who have comorbidities (e.g., maligant tumors, blood clotting abnormalities, etc.) that are inappropriate for clinical trial participation by the judgment of the researcher 6) Other who are judged by the researcher to be unsuitable for this clinical trial.
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ju Seok Ryu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juseok Ryu, M.D, PhD
Role: STUDY_DIRECTOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2206-761-302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.